Scott Gottlieb Quotes


For one thing, Medicaid is an inefficient if not ineffective platform for redistributing income. It doesn't get the dollars to poor people in forms that they can best use. Dollars are laundered through healthcare benefits that people may not need. It also means propping up a lot of healthcare interests rather than individual Americans.


Citations

Gottlieb, Scott. "To Fix Medicaid, Give States Real Flexibility." Forbes, 2017.

Related Quotes

That particular Libertarian platform called for the abolition / repeal of Social Security, Medicare, Medicaid, the Post Office, Federal election Commission and campaign finance laws. Extreme radical ideas such as this are not typical of Libertarian Party positions before or afterwards. The quotation illustrates that there are people in America who would end public education if they could. The quotation also illustrates how a small cadre of people can capture control of a political party and create a platform that is their own personal views which may be different from most of the party members or the historical position that the party has taken. In 1980 the Libertarian Party Vice Presidential Candidate was David Koch, one half of the billionaire conservative Koch brothers. Their money financed the Libertarian Party in that year and David Koch’s views then prevailed in the party platform. Historically, the Koch brothers moved from a minor third party to the Republican party at the beginning of the 21st century when their money was able to help drive the party very far to the right from the traditions of Abraham Lincoln and Theodore Roosevelt.


Scott Gottlieb
Scott Gottlieb
  • Born: June 11, 1972
  • Nationality: American
  • Profession: Public Servant

Scott Gottlieb is an American physician and investor who served as the 23rd commissioner of the Food and Drug Administration (FDA) from 2017 until April 2019. He is presently a resident fellow at the conservative think tank the American Enterprise Institute (AEI), a partner at the venture capital firm New Enterprise Associates (NEA), a member of the board of directors of drug maker Pfizer, Inc, a member of the board of directors of Illumina, Inc., and a contributor to the cable financial news network CNBC. Before becoming FDA commissioner, he was a clinical assistant professor at New York University School of Medicine, the FDA deputy commissioner for medical and scientific affairs, a venture partner with New Enterprise Associates, a member of the policy board of the Leukemia & Lymphoma Society, a senior official at the Centers for Medicare and Medicaid Services, and a member of the Federal Health Information Technology Policy Committee, which advises the United States Department of Health and Human Services on healthcare information technology. He was previously a resident fellow at AEI from 2007 to 2017 prior to joining the FDA as commissioner in May 2017.